HEPATOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-09-16 1dee6910m74(暂无匿称)

请教各位高手选审稿人的状态持续十一天了啥情况啊

240 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-09-02 1dee6910m74(暂无匿称)

请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表::
投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。

erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。

298 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-09-02 1dee6910m74(暂无匿称)

这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表::
投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。

erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。

224 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-08-17 ms4591412325009157

审稿速度:2.0 | 投稿命中率:75.0
经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。

23 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-07-21 cramp800

审稿速度:1.0 | 投稿命中率:25.0
经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。

254 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-05-13 miamihurricane

Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？

319 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-05-13 billzhangnju

投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。

243 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-05-05 miamihurricane

两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers...

211 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-03-25 zpfsjtu

Selecting/Assigning Reviewers 9天了。好慢呀。

212 0

[GetPortalCommentsPageByObjectIdResponse(id=527236, encodeId=e9ed52e2366f, content=请教各位高手选审稿人的状态持续十一天了啥情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=240, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 16 15:42:00 CST 2016, time=2016-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526688, encodeId=cafa526688a1, content=请问后来author agreement怎么处理的需要收集什么信息啊erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=298, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:50:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=526685, encodeId=ed135266852c, content=这个author agreement是要每个作者签字吗是不是投稿的时候这个材料就得准备好一起上传？erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, beContent=erudite 2015-12-06 发表:: 投稿后，是不是一定得 author agreement 收集完毕后才送外审啊？我投稿一周了，状态一直是 selecting/assigning reviewers。有哪位发表过的大神指点一下。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=11a91730063, createdName=1dee6910m74(暂无匿称), createdTime=Fri Sep 02 09:23:00 CST 2016, time=2016-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833111, encodeId=fb8c83311165, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：刚中了一篇，总体来说，该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8e55414120, createdName=ms4591412325009157, createdTime=Wed Aug 17 14:04:56 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=525037, encodeId=7f9952503e96, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：刚中了一篇，总体感觉该杂志需要一定的创新性及较完整研究证据链，和一定的转化应用潜能，对语言的要求不是特别高，编辑部比较友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=524172412, createdName=cramp800, createdTime=Thu Jul 21 10:18:00 CST 2016, time=2016-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522364, encodeId=987952236461, content=Selecting/Assigning Reviewers 也是9天了，请问zpfsjtu后来文章进展如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Fri May 13 22:04:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522341, encodeId=adec52234164, content=投稿一周了，状态栏一直是draft，是什么情况。是国外通讯作者老板投的，电邮联系他也没回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d1d1684804, createdName=billzhangnju, createdTime=Fri May 13 08:30:00 CST 2016, time=2016-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=522061, encodeId=9e8a5220614d, content=两天前刚投了一篇临床回顾性病例对照研究，首次证实并发现一个临床重要的问题，对指南可能具有一定的参考意义（当然毕竟是回顾性研究，证据强度有限，当然前瞻的RCT不太容易做）。投了“Rapid Communication”，希望快速通道审稿。目前Assigning Reviewers..., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=211, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=035c1683380, createdName=miamihurricane, createdTime=Thu May 05 20:30:00 CST 2016, time=2016-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520723, encodeId=41f7520e23cb, content=Selecting/Assigning Reviewers 9天了。好慢呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Fri Mar 25 22:14:00 CST 2016, time=2016-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=520436, encodeId=fa7e520436ba, content=投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/30/1fd71361aa1edb0dddb01f24368ce89d.jpg, createdBy=4b6080368, createdName=zpfsjtu, createdTime=Sat Mar 19 18:28:00 CST 2016, time=2016-03-19, status=1, ipAttribution=)]

2016-03-19 zpfsjtu

投稿第3天变成under review，第四天变成了Selecting/Assigning Reviewers现在已经三天了，不知道有没有送审呀。

215 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务